🇫🇷
France · FR · FR:67568483
ASPAVELI 1080 mg, solution pour perfusion
ReimbursedATC L04AJ03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerSWEDISH ORPHAN BIOVITRUM (SUEDE)
CountryFR (France)
ATC codeL04AJ03
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip1334009302436571 flacon(s) en verre de 20 mlEUR 3.3
- cip1334009302436718 flacon(s) en verre de 20 mlEUR 25.5
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67568483",
"date_amm": "2021-12-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1595",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}Related drugs
Other records sharing ATC code L04AJ03.
- PLAspaveliSwedish Orphan Biovitrum AB (publ)
- 🇨🇭AspaveliSwedish Orphan Biovitrum AG
- 🇨🇭Aspaveli
- NOAspaveliApellis Ireland Limited
- CZASPAVELISwedish Orphan Biovitrum AB (publ), Stockholm
- FIASPAVELISwedish Orphan Biovitrum AB (publ)
- CZASPAVELISwedish Orphan Biovitrum AB (publ), Stockholm
- ISASPAVELI*Swedish Orphan Biovitrum AB (publ)
Access this data programmatically
Query ASPAVELI 1080 mg, solution pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.